StocktwitsEarnings
Nov 4, 9:26 PM
$BTMD Q3 '26 Earnings Results & Recap
• Reported GAAP EPS of
$0.01 down -95.45% YoY
• Reported revenue of
$43.33M down -9.65% YoY
• Biote maintained 2026 guidance for revenue above
$175M and Adjusted EBITDA above
$25M; full-year dietary supplements revenue is expected to grow at a mid- to high-single-digit rate from 2025.
0 replies